TLRY Tilray Brands, Inc.

Nasdaq tilray.com


$ 1.70 $ 0.08 (5 %)    

Wednesday, 15-Oct-2025 18:07:28 EDT
QQQ $ 603.54 $ 4.22 (0.71 %)
DIA $ 462.77 $ 0.00 (0 %)
SPY $ 665.95 $ 2.94 (0.44 %)
TLT $ 90.72 $ -0.20 (-0.22 %)
GLD $ 387.16 $ 6.60 (1.73 %)
$ 1.68
$ 1.66
$ 1.69 x 13,209
$ 1.70 x 3,210
$ 1.57 - $ 1.84
$ 0.35 - $ 2.32
121,129,433
na
1.89B
$ 1.81
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-09-2025 08-31-2025 10-Q
2 07-28-2025 05-31-2025 10-K
3 04-08-2025 02-28-2025 10-Q
4 01-10-2025 11-30-2024 10-Q
5 10-10-2024 08-31-2023 10-Q
6 10-10-2024 08-31-2024 10-Q
7 07-29-2024 05-31-2024 10-K
8 04-09-2024 02-29-2024 10-Q
9 01-09-2024 11-30-2023 10-Q
10 10-04-2023 08-31-2023 10-Q
11 07-26-2023 05-31-2023 10-K
12 04-10-2023 02-28-2023 10-Q
13 01-09-2023 11-30-2022 10-Q
14 10-07-2022 08-31-2022 10-Q
15 07-28-2022 05-31-2022 10-K
16 04-06-2022 02-28-2022 10-Q
17 01-10-2022 11-30-2021 10-Q
18 10-07-2021 08-31-2021 10-Q
19 07-28-2021 05-31-2021 10-K
20 05-10-2021 03-31-2021 10-Q
21 02-19-2021 12-31-2020 10-K
22 11-09-2020 09-30-2020 10-Q
23 08-10-2020 06-30-2020 10-Q
24 05-11-2020 03-31-2020 10-Q
25 03-02-2020 12-31-2019 10-K
26 11-13-2019 09-30-2019 10-Q
27 08-13-2019 06-30-2019 10-Q
28 05-15-2019 03-31-2019 10-Q
29 03-25-2019 12-31-2018 10-K
30 11-14-2018 09-30-2018 10-Q
31 08-29-2018 06-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 tilray-stock-rises-as-study-links-medical-cannabis-to-lower-opioid-use

A Marijuana Moment report cites findings from a new study showing medical cannabis legalization leads to significant reductions...

Core News & Articles

https://www.marijuanamoment.net/legalizing-medical-marijuana-leads-to-significant-reductions-in-opioid-prescriptions-another-st...

 whats-going-on-with-tilray-brands-stock-today

Tilray slips despite unveiling a licensed Panama JV to expand its medical cannabis footprint and clinician-focused access.

Core News & Articles

NEW YORK, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Tilray Medical ("Tilray"), a division of Tilray Brands, Inc. (NASDAQ:TLRY, ...

 tilray-stock-is-sliding-friday-whats-going-on

Tilray Brands shares are trading lower Friday morning, a sharp reversal after the stock hit a new 52-week high on Thursday.

 tilray-brands-files-for-mixed-shelf

https://www.sec.gov/Archives/edgar/data/1731348/000114036125037823/ny20056674x1_s3asr.htm

 tilray-tlry-stock-surges-to-new-52-week-high-on-strong-q1-earnings-report

Tilray Brands shares are trading higher Thursday afternoon following the release of a strong first-quarter fiscal 2026 earnings...

 tilray-delivers-q1-earnings-surprise-strengthens-balance-sheet-with-lower-debt

Tilray stock surges after Q1 earnings beat estimates with break-even results, higher revenue, and improved balance sheet strength.

Core News & Articles

https://www.marijuanamoment.net/virginia-lawmakers-discuss-steps-to-prepare-state-to-legalize-recreational-marijuana-sales-next...

Core News & Articles

Tilray Medical a division of Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY) and a global leader in medicinal cannabis, empowering ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION